Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Apoptosis inducers in chronic lymphocytic leukemia

19 Nov 2013

Abstract excerpt

// Christian Billard 1,2 1 INSERM U 872, Centre de Recherche des Cordeliers, Equipe 18, Paris, France 2 Université Pierre et Marie Curie (UMRS 872), Paris, France. Correspondence: Christian Billard, email: // Keywords : CLL; impaired cell death program; apoptosis-targeted therapies; apoptosis inducers; Bcl-2 family proteins. Received : October 8, 2013 Accepted : November 18, 2013 Published : November 19, 2013...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related Molecular Pathways
Share to Cell death mechanisms and regulation
Share to Chronic Lymphocytic Leukemia Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24525395
DOI: 10.18632/oncotarget.1480

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Apoptosis inducers in chronic lymphocytic leukemiaPMID 24525395Read ↗

Potential New Therapies “ROS-Based” in CLL: An Innovative Paradigm in the Induction of Tumor Cell ApoptosisSemantic proximity Read ↗

Bodyguards and assassins: Bcl‐2 family proteins and apoptosis control in chronic lymphocytic leukaemiaSemantic proximity Read ↗

Deregulation of New Cell Death Mechanisms in LeukemiaSemantic proximity Read ↗

Comprehensive review of Bcl‐2 family proteins in cancer apoptosis: Therapeutic strategies and promising updates of natural bioactive compounds and small moleculesSemantic proximity Read ↗

A Novel Paradigm to Trigger Apoptosis in Chronic Lymphocytic LeukemiaSemantic proximity Read ↗

Therapeutic advancements in targeting BCL-2 family proteins by epigenetic regulators, natural, and synthetic agents in cancerSemantic proximity Read ↗

Apoptosis and Pharmacological Therapies for Targeting Thereof for Cancer TherapeuticsSemantic proximity Read ↗

BCL-2 Proteins in Pathogenesis and Therapy of B-Cell Non-Hodgkin LymphomasSemantic proximity Read ↗

Apoptosis in Cancer Biology and TherapySemantic proximity Read ↗

The Role of BCL2 Family of Apoptosis Regulator Proteins in Acute and Chronic LeukemiasSemantic proximity Read ↗

Potential of apoptotic pathway-targeted cancer therapeutic research: Where do we stand?Semantic proximity Read ↗

Comprehensive landscape of cell death mechanisms: from molecular cross-talk to therapeutic innovation in oncologySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.